These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel. Ramalingam S Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S77-82. PubMed ID: 16384540 [TBL] [Abstract][Full Text] [Related]
5. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy. Khuri FR Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898 [TBL] [Abstract][Full Text] [Related]
6. New options in the treatment of non-small cell lung cancer. Fossella F; Rigas JR; Belani CP Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365 [TBL] [Abstract][Full Text] [Related]
7. Taxanes, past, present, and future impact on non-small cell lung cancer. Joshi M; Liu X; Belani CP Anticancer Drugs; 2014 May; 25(5):571-83. PubMed ID: 24463482 [TBL] [Abstract][Full Text] [Related]
8. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer. Belani CP Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542 [TBL] [Abstract][Full Text] [Related]
9. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer. Gandara DR; Edelman MJ; Lau D Semin Oncol; 1999 Jun; 26(3 Suppl 10):3-7. PubMed ID: 10437743 [TBL] [Abstract][Full Text] [Related]
10. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer. Harper P Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522 [TBL] [Abstract][Full Text] [Related]
11. Taxane-platinum combinations in advanced non-small cell lung cancer: a review. Rigas JR Oncologist; 2004; 9 Suppl 2():16-23. PubMed ID: 15161987 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel in non-small cell lung cancer: a review. Davies AM; Lara PN; Mack PC; Gandara DR Expert Opin Pharmacother; 2003 Apr; 4(4):553-65. PubMed ID: 12667118 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170 [TBL] [Abstract][Full Text] [Related]